PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826F0AAS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $838,753
Award facts
- Contract value 100% obligated
- $838,752.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a Delivery Order (DO) valued at $838,752.65 from the Defense Logistics Agency's Medical Supply Chain on October 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by October 7, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
This delivery order represents a continuation of AmerisourceBergen's established role as a critical federal medical procurement vendor. The company's contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical and medical supply requirements for federal agencies including the Defense Health Agency and U.S. Coast Guard. As a prime vendor under the DLA's pharmaceutical procurement framework, AmerisourceBergen participates in the broader Pharmaceutical Prime Vendor Global Program, which the DLA plans to expand through Generation V contracts with multiple regional awards to different contractors, underscoring the strategic importance of reliable pharmaceutical distribution to the Defense Department's medical supply chain.
Quick answers
Who was awarded contract SPE2D826F0AAS?
SPE2D826F0AAS was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on October 6, 2025.
How much is contract SPE2D826F0AAS worth?
The government has obligated $838,753 on SPE2D826F0AAS.
Is contract SPE2D826F0AAS an order under another contract?
Yes. SPE2D826F0AAS is a delivery order under SPE2DX22D0129, an indefinite delivery contract.
Was contract SPE2D826F0AAS competed?
The extent of competition for SPE2D826F0AAS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award